title: Effectiveness of screening aqueous contrast swallow in detecting clinically significant anastomotic leaks after esophagectomy.
abstract: BACKGROUND
  Aqueous contrast swallow study is recommended as a screening procedure for the evaluation of esophageal anastomotic integrity following esophagectomy. The aim of this study was to assess the accuracy of water-soluble contrast swallow screening as a predictor of clinically significant anastomotic leak in patients with esophagectomy.
  
  
  METHODS
  The records of 505 consecutive patients undergoing esophagectomy in Mayo Clinic from January 1991 through December 1995 were retrospectively reviewed. 464 (92%) patients had water-soluble contrast swallows performed in the early postoperative period (median postoperative day 7, range 4-11 days).
  
  
  RESULTS
  A total of 39 radiological leaks were obtained but only 17 of these had clinical signs of anastomotic leakage. Furthermore, 25 patients who had normal swallow study developed a clinical anastomotic leak. There were therefore 22 (4.7%) false positive and 25 (5.4%) false negative results giving values for the specificity, sensitivity and false negative error rate of the radiological examination of 94.7, 40.4, and 59.5% respectively. Aspiration of the contrast agent was noted on fluoroscopy in 30 (6.5%) patients. Only 2 (0.4%) patients developed aqueous contrast agent-caused aspiration pneumonia. There was no procedure-related mortality.
  
  
  CONCLUSIONS
  While radiological assessment of esophageal anastomoses in the early postoperative period using aqueous contrast agents appears to be a relatively safe procedure, the poor sensitivity and high false negative error rate of this technique, when performed on postoperative day 7 and in a series with clinical anastomotic leak rate of 9%, is insufficient for it to be worthwhile as a screening procedure.
authors.affiliation: Section of General Thoracic Surgery, Mayo Clinic and Foundation, Rochester, Minn., USA. mbulent@hacettepe.edu.tr
authors.forename: M B
authors.initials: MB
authors.lastname: Tirnaksiz
authors.forename: C
authors.initials: C
authors.lastname: Deschamps
authors.forename: M S
authors.initials: MS
authors.lastname: Allen
authors.forename: D C
authors.initials: DC
authors.lastname: Johnson
authors.forename: P C
authors.initials: PC
authors.lastname: Pairolero
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000714:Anastomosis, Surgical; D002648:Child; D002675:Child, Preschool; D003287:Contrast Media / Q000008:administration & dosage*; D003974:Diatrizoate Meglumine / Q000008:administration & dosage*; D016629:Esophagectomy; D005188:False Negative Reactions; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D011183:Postoperative Complications / Q000000981:diagnostic imaging*; D011859:Radiography; D012189:Retrospective Studies
chemical_list: D003287:Contrast Media; D003974:Diatrizoate Meglumine